Clinical Trials
7 trialsNCT01745588 2025-09-11
Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00151203 2021-05-27
Phase II Study of Biaxin, Revlimid, and Dexamethasone for Untreated Multiple Myeloma
Weill Medical College of Cornell University
Phase 2 Completed
NCT00538733 2021-05-24
T-BiRD
Weill Medical College of Cornell University
Phase 2 Completed
NCT00445692 2019-11-13
Lenalidomide, Dexamethasone, and Clarithromycin in Treating Patients Who Have Undergone Stem Cell Transplant for Multiple Myeloma
Fred Hutchinson Cancer Center
Phase 2 Completed
NCT01159574 2019-06-11
Study of Decadron, Biaxin, and Pomalidomide in Relapsed/Refractory Myeloma
Weill Medical College of Cornell University
Phase 2 Completed
NCT00182663 2017-06-26
Thalidomide, Dexamethasone, and Clarithromycin in Treating Patients With Multiple Myeloma Previously Treated With Transplant
Fred Hutchinson Cancer Center
Phase 2 Completed
NCT00006219 2011-08-04
Chemoprevention Therapy in Treating Patients at High Risk of Developing Multiple Myeloma
Mayo Clinic
Phase 2 Completed